Cargando…
Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis
PURPOSE: Concurrent chemoradiation (CCRT) is the standard curative treatment of anal canal cancer (ACC). The role of a brachytherapy (BRT) boost in this setting is still debated. Therefore, the aim of this analysis was to retrospectively evaluate the clinical outcomes in a large cohort of ACC patien...
Autores principales: | Arcelli, Alessandra, Buwenge, Milly, Macchia, Gabriella, Cammelli, Silvia, Deodato, Francesco, Cilla, Savino, Galuppi, Andrea, Panni, Valeria, Mattiucci, Gian Carlo, Tagliaferri, Luca, Morganti, Alessio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431102/ https://www.ncbi.nlm.nih.gov/pubmed/30911306 http://dx.doi.org/10.5114/jcb.2019.82804 |
Ejemplares similares
-
Brachytherapy boost after chemoradiation in anal cancer: a systematic review
por: Frakulli, Rezarta, et al.
Publicado: (2018) -
Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017) -
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review
por: Scirocco, Erica, et al.
Publicado: (2021) -
Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose‐escalation feasibility study
por: Cilla, Savino, et al.
Publicado: (2018) -
The role of training simulators in interventional radiation therapy (brachytherapy) training: A narrative review
por: Ferioli, Martina, et al.
Publicado: (2023)